These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21496834)

  • 1. The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
    Boris RS; Benhammou J; Merino M; Pinto PA; Linehan WM; Bratslavsky G
    J Urol; 2011 Jun; 185(6):2050-5. PubMed ID: 21496834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
    Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
    Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Birt-Hogg-Dubé syndrome: an update].
    López V; Jordá E; Monteagudo C
    Actas Dermosifiliogr; 2012 Apr; 103(3):198-206. PubMed ID: 21937013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
    Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
    Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations.
    Adley BP; Smith ND; Nayar R; Yang XJ
    Arch Pathol Lab Med; 2006 Dec; 130(12):1865-70. PubMed ID: 17149965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.
    Lang M; Vocke CD; Merino MJ; Schmidt LS; Linehan WM
    Mod Pathol; 2015 Nov; 28(11):1458-69. PubMed ID: 26428318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors.
    Wu J; Lu J; Wu CL; Lu M
    Semin Diagn Pathol; 2024 May; 41(3):119-124. PubMed ID: 38242750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.
    Schmidt LS; Nickerson ML; Warren MB; Glenn GM; Toro JR; Merino MJ; Turner ML; Choyke PL; Sharma N; Peterson J; Morrison P; Maher ER; Walther MM; Zbar B; Linehan WM
    Am J Hum Genet; 2005 Jun; 76(6):1023-33. PubMed ID: 15852235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging entities in renal cell neoplasia: thyroid-like follicular renal cell carcinoma and multifocal oncocytoma-like tumours associated with oncocytosis.
    Eble JN; Delahunt B
    Pathology; 2018 Jan; 50(1):24-36. PubMed ID: 29132724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
    Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
    Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms.
    Gatalica Z; Lilleberg SL; Vranic S; Eyzaguirre E; Orihuela E; Velagaleti G
    Hum Pathol; 2009 Dec; 40(12):1813-9. PubMed ID: 19733897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal tumors in the Birt-Hogg-Dubé syndrome.
    Pavlovich CP; Walther MM; Eyler RA; Hewitt SM; Zbar B; Linehan WM; Merino MJ
    Am J Surg Pathol; 2002 Dec; 26(12):1542-52. PubMed ID: 12459621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DIAGNOSIS OF GENETIC VARIANT CARRIERS IN A PATIENT WITH ASYMPTOMATIC BIRT-HOGG-DUBÉ SYNDROME: A CASE REPORT].
    Watari S; Ichikawa T; Hirasawa A; Shiraishi H; Tokunaga M; Kubota R; Kusumi N; Tsushima T; Shinno Y; Furuya M
    Nihon Hinyokika Gakkai Zasshi; 2023; 114(2):61-65. PubMed ID: 38644188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.
    Murakami T; Sano F; Huang Y; Komiya A; Baba M; Osada Y; Nagashima Y; Kondo K; Nakaigawa N; Miura T; Kubota Y; Yao M; Kishida T
    J Pathol; 2007 Apr; 211(5):524-531. PubMed ID: 17323425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
    Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
    Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
    Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.